Considerations of expanded carrier screening: Lessons learned from combined malonic and methylmalonic aciduria
- PMID:33625768
- PMCID: PMC8123733
- DOI: 10.1002/mgg3.1621
Considerations of expanded carrier screening: Lessons learned from combined malonic and methylmalonic aciduria
Abstract
Background: Expanded carrier screening (ECS) utilizes high-throughput next-generation sequencing to evaluate an individual's carrier status for multiple conditions. Combined malonic and methylmalonic aciduria (CMAMMA) due to ACSF3 deficiency is a rare inherited disease included in such screening panels. Some cases have been reported with metabolic symptoms in childhood yet other cases describe a benign clinical course, suggesting the clinical phenotype is not well defined.
Methods/case report: Clinical and laboratory findings during the prenatal period were obtained retrospectively from medical records.
Results: A 37-year-old nulliparous woman and her partner were each identified as carriers of ACSF3 variants and presented at 9 weeks gestation for prenatal genetic consultation. The couple received extensive genetic counseling and proceeded with chorionic villus sampling at 11 weeks gestation. Subsequent analysis confirmed that the fetus inherited both parental ACSF variants. The couple was devastated by the results and after reviewing options of pregnancy continuation and termination, they decided to terminate the pregnancy. Following this decision, the patient was diagnosed with acute stress disorder.
Conclusion: This case highlights how expanded carrier screening adds complexity to reproductive decision-making. Stronger guidelines and additional research are needed to direct and evaluate the timing, composition, and implementation of ECS panels.
Keywords: ACSF; CMAMMA; expanded carrier screening; genetic counseling.
© 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Similar articles
- Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype.Alfares A, Nunez LD, Al-Thihli K, Mitchell J, Melançon S, Anastasio N, Ha KC, Majewski J, Rosenblatt DS, Braverman N.Alfares A, et al.J Med Genet. 2011 Sep;48(9):602-5. doi: 10.1136/jmedgenet-2011-100230. Epub 2011 Jul 23.J Med Genet. 2011.PMID:21785126
- Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria.Sloan JL, Johnston JJ, Manoli I, Chandler RJ, Krause C, Carrillo-Carrasco N, Chandrasekaran SD, Sysol JR, O'Brien K, Hauser NS, Sapp JC, Dorward HM, Huizing M; NIH Intramural Sequencing Center Group; Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, Nyhan WL, Biesecker LG, Venditti CP.Sloan JL, et al.Nat Genet. 2011 Aug 14;43(9):883-6. doi: 10.1038/ng.908.Nat Genet. 2011.PMID:21841779Free PMC article.
- Combined malonic and methylmalonic aciduria due to ACSF3 mutations: Benign clinical course in an unselected cohort.Levtova A, Waters PJ, Buhas D, Lévesque S, Auray-Blais C, Clarke JTR, Laframboise R, Maranda B, Mitchell GA, Brunel-Guitton C, Braverman NE.Levtova A, et al.J Inherit Metab Dis. 2019 Jan;42(1):107-116. doi: 10.1002/jimd.12032.J Inherit Metab Dis. 2019.PMID:30740739
- Prenatal genetic carrier screening in the genomic age.Gregg AR, Edwards JG.Gregg AR, et al.Semin Perinatol. 2018 Aug;42(5):303-306. doi: 10.1053/j.semperi.2018.07.019. Epub 2018 Jul 26.Semin Perinatol. 2018.PMID:30241949Review.
- Expanded Carrier Screening.Gregg AR.Gregg AR.Obstet Gynecol Clin North Am. 2018 Mar;45(1):103-112. doi: 10.1016/j.ogc.2017.10.005.Obstet Gynecol Clin North Am. 2018.PMID:29428278Review.
Cited by
- Genetic Counselling Needs for Reproductive Genetic Carrier Screening: A Scoping Review.Edwards S, Laing N.Edwards S, et al.J Pers Med. 2022 Oct 11;12(10):1699. doi: 10.3390/jpm12101699.J Pers Med. 2022.PMID:36294838Free PMC article.
References
- Alfares, A. , Nunez, L. D. , Al‐Thihli, K. , Mitchell, J. , Melancon, S. , Anastasio, N. , Ha, K. C. H. , Majewski, J. , Rosenblatt, D. S. , & Braverman, N. (2011). Combined malonic and methylmalonic aciduria: Exome sequencing reveals mutations in the ACSF3 gene in patients with a non‐classic phenotype. Journal of Medical Genetics, 48(9), 602–605. 10.1136/jmedgenet-2011-100230 - DOI - PubMed
- American College of Obstetricians and Gynecologists . (2017). Committee opinion no. 690: Carrier screening in the age of genomic medicine. Obstetrics & Gynecology, 129(3), e35–e40. - PubMed
- Edwards, J. G. , Feldman, G. , Goldberg, J. , Gregg, A. R. , Norton, M. E. , Rose, N. C. , Schneider, A. , Stoll, K. , Wapner, R. , & Watson, M. S. (2015). Expanded carrier screening in reproductive medicine—points to consider: A joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal‐Fetal Medicine. Obstetrics & Gynecology, 125(3), 653–662. 10.1097/AOG.0000000000000666 - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical